These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13090767)

  • 1. [Effect of 2-phenyl-1-3-diketohydrindene on blood coagulation].
    SCHMID J; VINAZZER H
    Wien Z Inn Med; 1953 May; 34(5):194-9. PubMed ID: 13090767
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of phenylindanedione on blood coagulation].
    CASULA D
    Rass Med Sarda; 1955; 57(3-4):153-62. PubMed ID: 13290063
    [No Abstract]   [Full Text] [Related]  

  • 3. The mode of action of phenylindanedione.
    WALKER W; HUNTER RB
    J Clin Pathol; 1954 Aug; 7(3):249-51. PubMed ID: 13192203
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research on anticoagulant effect of phenylindanedione and its relation to the substances with vitamin P effect].
    LONGO G
    Haematologica; 1954; 38(9):1161-8. PubMed ID: 13221125
    [No Abstract]   [Full Text] [Related]  

  • 5. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 6. A one stage method for the assay of antihemophilic factor B (AHF B) with a comment on the antihemophilic factor B (AHF B) concentration in phenylindanedione (PID) therapy.
    STAPP WF
    Scand J Clin Lab Invest; 1958; 10(2):169-76. PubMed ID: 13602673
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the anticoagulant phenindione. IV. Its multiphasic effect on the coagulation mechanism.
    ADAMIS D; KIMBALL D; SISE HS
    J Lab Clin Med; 1957 Jan; 49(1):69-83. PubMed ID: 13385578
    [No Abstract]   [Full Text] [Related]  

  • 8. Levels of blood-coagulation factors during anticoagulant therapy with phenindione.
    DENSON KW
    Br Med J; 1961 Apr; 1(5234):1205-10. PubMed ID: 13721922
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of administration of phenindione on blood levels of prothrombin, autoprothrombin I and autoprothrombin II.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    J Appl Physiol; 1958 Nov; 13(3):411-6. PubMed ID: 13587424
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of phenindione and bed rest on blood coagulability following a high-fat intake.
    MCDONALD GA; FULLERTON HW
    Lancet; 1960 Nov; 2(7160):1111-2. PubMed ID: 13773865
    [No Abstract]   [Full Text] [Related]  

  • 11. Mode of action of coumarin drugs.
    DOUGLAS AS
    Br Med Bull; 1955; 11(1):39-44. PubMed ID: 13230473
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihemophilic globulin consumption during blood coagulation.
    DOUGLAS AS
    Blood; 1956 May; 11(5):423-9. PubMed ID: 13315504
    [No Abstract]   [Full Text] [Related]  

  • 13. [Modification of coagulation factor IX by hydroxycoumarin and phenylindandione derivatives].
    EGLI H; SCHNEIDER W
    Thromb Diath Haemorrh; 1961 Sep; 6():331-8. PubMed ID: 13889446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenylindanedione as an anti-coagulant].
    PREZIOSI P
    Riforma Med; 1953 Jun; 67(25):696. PubMed ID: 13089422
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect on different clotting factors of short-term treatment with phenylindanedione.
    EGEBERG O
    Scand J Clin Lab Invest; 1962; 14():247-52. PubMed ID: 13889406
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical use of a new anticoagulant, phenylindanedione; report of 400 cases.
    BLAUSTEIN A; SHNAYERSON N; WALLACH R
    Am J Med; 1953 Jun; 14(6):704-6. PubMed ID: 13057880
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of phenylindanedione and dicumarol in experimental frostbite.
    LEPP E; CHUBATY W; JACQUES LB
    Can J Med Sci; 1953 Jun; 31(3):173-81. PubMed ID: 13059674
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the hypoprothrombinemic effect of 2-naphthoxyindandione-(1,3) and 2-tetrahydronaphthylindandiones-(1,3). 30. On the phthalides and indandiones].
    Hrnciar P; Lácová M; Kovalcík V
    Pharmazie; 1968 Sep; 23(9):499-500. PubMed ID: 5717188
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the behavior of the Hageman factor and plasma thromboplastin antecedent (PTA) under the influence of hydroxycoumarin and phenylindanedione administration].
    RODERMUND OE; SCHNEIDER W; EGLI H
    Thromb Diath Haemorrh; 1961 Apr; 5():595-6. PubMed ID: 13742528
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulant activities of some 2-acyl-1, 3-indandiones.
    Bond HW; Dedhiya MG; Carlson GP
    Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):288-91. PubMed ID: 4800265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.